Category,Source,Year,Market_Size_USD_B,Basis
Market Forecast,Goldman Sachs,2023,100,Global GLP-1 adoption and obesity drug expansion
Market Forecast,Morgan Stanley,2024,130,Long-term obesity treatment market outlook
Market Forecast,Bloomberg Intelligence,2024,120,GLP-1 drug demand and supply scaling
Company Revenue,Novo Nordisk,2024,65,GLP-1 sales including Wegovy and Ozempic
Company Revenue,Eli Lilly,2024,45,Tirzepatide sales including Mounjaro and Zepbound
Public Health,WHO,2022,,Global obesity prevalence continues to rise
Public Health,CDC,2023,,Adult obesity rate exceeds 40 percent in the US
